ACDRS 2025 Course
The Course emphasizes integrated product development that is science-based, efficient, economical, high quality, and rapid, leading to better and safer medical products for patients.
See how this rigorous, in-depth, comprehensive, and systematic immersion into modern medical product development, regulation, and market introduction can benefit your career by viewing testimonials from former ACDRS Course participants.
Dates and session themes |
||
Jan 29, 2025 |
First day of instruction |
|
---|---|---|
Jan 29-31, 2025 |
Session 1 |
The Medical Product Development Enterprise: Past, Present, and Future Perspectives |
Mar 5-7, 2025 |
Session 2 |
Learning Trials: From Discovery to First in Humans |
Apr 2-4, 2025 |
Session 3 |
Learning and Confirming Trials: Finding and Confirming the Right Dose |
May 14-16, 2025 |
Session 4 |
Statistics: Design, Analysis, and Interpretation of Clinical Trials |
Sep 10-12, 2025 |
Session 5 |
Global Clinical Trials Authorization and Marketing Authorization Processes |
Oct 22-24, 2025 |
Session 6 |
Integrated Product Development, Portfolio Management, Project Management, and Preparing for Transition to the Market |
Oct 24, 2025 |
Last day of instruction |
|
Examination |
December 20, 2024 |
Cancellation deadline |
---|
This is a hybrid course with the option to attend in-person (in DC) or virtually (via Zoom) for three days of eight hours each day.
See the Course for topics and learning outcomes
Venue
University of California, Washington Center (UCDC), 1608 Rhode Island Ave NW, Washington, DC
Eligibility
You must:
-
have a higher university degree, such as MD, PharmD, PhD, Master’s, or JD (Applicants without terminal degrees but with extensive product development will be considered)
-
have a primary interest in medical product discovery, development, regulation, or related activity
-
have at least one year of work experience in medical product development
-
be qualified via standards and nominations by submitting a one-page curriculum vitae to [email protected] prior to or immediately following registration
Register
Registration fee: $15,000.00
A discounted fee for a limited number of participants from academia and government is available, please contact [email protected].
Enrollment is limited. You are encouraged to register well in advance. In case of cancellation before December 20, 2024 the fee (less $500.00 for administrative expenses) will be returned. There will be no substitute registrants or refund on cancellations made after this date.
For additional details, see FAQ.
—Joe Rappon, VP and Head of Pharma, Alcon